NovaSom

NovaSom

NovaSom | Home Sleep Testing for Sleep Apnea.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

$3.7m

Debt
Total Funding000k
Notes (0)
More about NovaSom
Made with AI
Edit

NovaSom, Inc. operated as a diagnostic service provider focused on home-based testing for obstructive sleep apnea (OSA). Founded in 1992 and formerly known as Sleep Solutions, Inc., the company established itself as a pioneer in the remote sleep diagnostics market. It secured the first FDA clearance for an unattended home sleep test designed for patient use, a significant milestone that offered a more convenient alternative to traditional, lab-based polysomnography.

The company's business model revolved around providing these diagnostic services to physicians, private insurers, and government health organizations. NovaSom's primary product was a home sleep testing (HST) device, the AccuSom, which recorded key respiratory and cardiac data overnight. This device featured wireless data transmission via an integrated cell chip, allowing for next-day test results. The data was uploaded to a proprietary, cloud-based platform called MediTrack, where sleep specialists could review the information and provide a diagnosis to the ordering physician. Revenue was generated by billing for these diagnostic tests, positioning the service as a cost-effective method for payers to manage the high costs associated with undiagnosed and untreated OSA.

Throughout its history, NovaSom attracted substantial investment from prominent backers, including Johnson & Johnson's venture capital arm, TPG Biotech, and Safeguard Scientifics, raising over $55 million in multiple funding rounds. Despite its technological advancements and established market presence, the company faced financial difficulties. After developing a new wireless device between 2010 and 2012, sales did not meet expectations, and NovaSom failed to achieve profitability. Following unsuccessful attempts to find a buyer or secure further growth capital, NovaSom filed for Chapter 11 bankruptcy in August 2019. The company's assets were ultimately acquired by SleepMed, a subsidiary of the French technology firm BioSerenity, for $5.5 million in October 2019. Keywords: Obstructive Sleep Apnea, home sleep testing, HST, OSA diagnostics, AccuSom, MediTrack, remote patient monitoring, sleep-disordered breathing, diagnostic services, medical device, telehealth, ambulatory care, sleep medicine, FDA cleared, BioSerenity, SleepMed, VirtuOx, Johnson & Johnson, TPG Biotech, Safeguard Scientifics, remote diagnostics

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo